Source: International Congress 2014 – COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bertó Botella, V. Pinto-Plata, M. Divo, J. M. Marín, B. Celli, C. Casanova, C. Cabrera, J. Zagaceta, P. Sánchez-Salcedo, E. López-Zalduendo, J. Zulueta, J. P. Juan Pablo, B. Celli (Pamplona, Spain; Boston, United States Of America). The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD. Eur Respir J 2014; 44: Suppl. 58, 533

Member's Comments

No comment yet.

Related content which might interest you: COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 COPD staging systems and BODE index Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014 Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 CAT’ or ’mMRC’ – Which is a better symptom scale in recent GOLD COPD classification? Source: International Congress 2015 – COPD: interesting notes Year: 2015 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Adrenomedullin optimizes mortality prediction in COPD Source: International Congress 2014 – COPD exacerbations Year: 2014